ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xevudy, Konzentrat zur Herstellung einer Infusionslösung - 
68471001 GlaxoSmithKline AG
Xevudy, Konzentrat zur Herstellung einer Infusionslösung14.01.2022
  14.01.2022
(J06BD05) 
WHO-DDD18.03.2029
 
08.03. 
A  
No 
IP 
PR  
k.A.PR
  
7680684710018Biotechnologika
  
Composition
sotrovimabum 500 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, aqua ad iniectabile q.s. ad solutionem pro 8 ml.
Packungsbestandteile
Concentrate for infusion
 
 
Active AgentDose
Sotrovimabum500mg / 8ml
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
Saccharum
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home